Campbell & Co Investment Adviser’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.53M Buy
161,258
+117,856
+272% +$1.51M 0.13% 247
2026
Q1
$359K Buy
43,402
+4,557
+12% +$41.2K 0.02% 839
2025
Q4
$373K Buy
38,845
+21,575
+125% +$204K 0.02% 921
2025
Q3
$164K Buy
+17,270
New +$145K 0.01% 1026
2023
Q4
– Sell
-24,891
Closed -$341K – 1143
2023
Q3
$341K Buy
+24,891
New +$367K 0.04% 670
2022
Q4
– Sell
-38,800
Closed -$945K – 808
2022
Q3
$945K Buy
+38,800
New +$1.34M 0.21% 140

Other funds holding CYRX

Campbell & Co Investment Adviser's CYRX Position: Q2 2026 in Review

Campbell & Co Investment Adviser increased its CryoPort (CYRX) stake by 272% in Q2 2026, buying an estimated $1.51M and bringing the position to 161,258 shares worth $2.53M. The position accounts for 0.13% of the portfolio, ranked #247.

Campbell & Co Investment Adviser first reported a position in CYRX in Q3 2022 and has held it in 6 quarters since. 184 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

  • Campbell & Co Investment Adviser held 161,258 shares of CryoPort worth $2.53M as of Q2 2026.
  • Campbell & Co Investment Adviser bought 117,856 CryoPort shares in Q2 2026, an estimated $1.51M.
  • CryoPort made up 0.13% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #247 holding.
  • Campbell & Co Investment Adviser first reported a position in CryoPort in Q3 2022 and has held it in 6 quarters since.
  • 184 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.